Prognostic Proof and Possible Therapeutic Mechanisms of Herbal Medicine in Patients With Metastatic Lung and Colon Cancer
Open Access
- 22 September 2011
- journal article
- research article
- Published by SAGE Publications in Integrative Cancer Therapies
- Vol. 10 (3) , NP1-NP11
Abstract
Recent studies based on epidemiological models published in this journal and elsewhere have demonstrated encouraging patterns suggesting that herbal treatment may improve prognosis in advanced colon and lung cancer patients. Various problems exist with data from nonrandomized studies of this type, but a strong signal of potential positive effect can be seen. The therapeutic mechanisms of traditional Chinese medicine in metastatic cancer are discussed against a hypothetical, dualistic antiproliferation model and immune-stimulation model of tumor progression and regression. Recommendations are made for a strategy to demonstrate more conclusively the efficacy of adjunct herbal treatment during cancer chemotherapy and for discussions with patients until such time as the efficacy trials are completed.Keywords
This publication has 33 references indexed in Scilit:
- Serum estrogen and tumor-positive estrogen receptor-alpha are strong prognostic classifiers of non-small-cell lung cancer survival in both men and womenCarcinogenesis, 2010
- Lung cancer in women: role of estrogensExpert Review of Respiratory Medicine, 2010
- Could recombinant insulin compounds contribute to adenocarcinoma progression by stimulating local angiogenesis?Diabetologia, 2010
- Cancer patients' attitudes towards Chinese medicine: a Hong Kong surveyChinese Medicine, 2009
- Gefitinib or Carboplatin–Paclitaxel in Pulmonary AdenocarcinomaNew England Journal of Medicine, 2009
- Physical activity and breast cancer survivalBreast Cancer Research, 2009
- Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR MutationClinical Cancer Research, 2009
- Insulin and insulin-like growth factor signalling in neoplasiaNature Reviews Cancer, 2008
- HLA class I antigen expression is associated with a favorable prognosis in early stage non‐small cell lung cancerCancer Science, 2007
- The value of serum S-100β and interleukins as tumour markers in advanced melanomaMelanoma Research, 2000